|
|
|
| Wockhardt gets FDA nod for Nicardipine injections | 18-NOV-09 |
|
| Drug firm Wockhardt today said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections in 25mg/10 ml strength, used in the treatment of hypertension. |
|
|
|
|
|
|
|
|
|
| Reametrix scouts for strategic partners | 16-NOV-09 |
|
| Reametrix, a Bangalore-based company that provides basic research and assay development services to biotechnology and pharmaceutical companies, is scouting for strategic partners to take TriTstat, a critical diagnostic product for managing HIV patients, to the global markets. |
|
|
|
| Glenmark Generics gets US FDA nod for Ciclopirox Olamine | 14-NOV-09 |
|
| Glenmark Generics today said it has received ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ciclopirox Olamine cream, used in the treatment of dermatological infections. |
|
|
|
|
|
|
|
|
|
| USFDA tells Glenmark to withdraw drug | 15-OCT-09 |
|
| The US Food and Drug Administration (FDA) has directed Glenmark's US arm, Glenmark Generics Inc, and three other manufacturers to stop the marketing of unapproved codeine sulphate tablets in the US market. The drug is an old narcotics product widely used to treat pain. |
|
|
|
| Exclusivity gains | 05-OCT-09 |
|
| While the FDA approval for an antibiotic should improve revenue visibility and help Orchid Chemicals reduce debt, the upsides are priced in. |
|
|
|
| Aurobindo gets US FDA nod | 19-SEP-09 |
|
| Aurobindo Pharma Limited has received the tentative approval for Atomoxetine Hydrochloride capsules in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strengths. |
|
|
|
|
|
|
| Sun, Caraco to file 30 marketing applications for generics | 17-SEP-09 |
|
| Sun Pharmaceutical Industries and its troubled US subsidiary, Caraco Pharmaceuticals, plan to together file 30 Abbreviated New Drug Applications with the US Food and Drug Administration (FDA) to market generic drugs, despite regulatory issues for the US company. |
|
|
|
| Suven Life gets two more US patents for NCEs | 14-SEP-09 |
|
| Suven Life Sciences Limited, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, has received patents for two new chemical entities (NCEs) from the US Patent office. |
|
|
|
|
|
|
Content Guide
